Heptares to help Pfizer deliver GPCRs
Executive Summary
Sosei Group Corp.'s Heptares Therapeutics Ltd. will use its GPCR structure-guided platform to help deliver stabilized G protein-coupled receptors (GPCRs), known as StaR proteins, to Pfizer Inc.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Technologies
- Genomics-Proteomics
-
Drug Discovery Technologies
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice